Environmental

CAH’s environmental profile is mixed versus peers because low R&D intensity limits innovation in lower-impact logistics and packaging, though this is not a clear structural disadvantage.

The company’s healthcare distribution model likely carries material Scope 3 exposure from transportation and product handling, leaving it broadly similar to large peers rather than distinctly advantaged.

No provided filing evidence indicates leading emissions disclosure or decarbonization execution, so its environmental positioning appears adequate but not top-tier versus diversified healthcare distributors.

Operational efficiency can reduce waste and energy intensity across warehousing and distribution, but the available metrics do not show a peer-leading environmental cost structure.

Social

CAH’s social positioning is supported by the essential nature of pharmaceutical and medical distribution, which makes service continuity and patient access more material than in many peers.

The business model creates elevated product-safety and traceability expectations, but these are industry-wide obligations rather than a clear relative weakness versus peers.

Low stock-based compensation to revenue suggests limited reliance on equity incentives, which can support workforce alignment and reduce compensation-related social friction versus peers.

No latest filing evidence provided here indicates major labor, customer, or community controversies, so the social profile appears solid relative to healthcare distribution peers.

Governance

CAH’s leverage profile is manageable but not exceptional, and higher debt dependence can constrain governance flexibility relative to more conservatively financed peers.

The negative debt-to-equity metric suggests balance-sheet distortions in the reported data, which reduces comparability and limits confidence in governance assessment versus peers.

Low stock-based compensation indicates restrained dilution and potentially tighter capital discipline, but this alone does not establish superior governance versus peers.

No filing-based evidence of board, audit, or controversy issues is provided, so governance appears broadly acceptable rather than clearly leading in the peer set.

Overall Score

CAH’s ESG profile is broadly acceptable versus peers, with stronger social positioning offset by only moderate environmental and governance differentiation.

Score Driver: Essential Healthcare Distribution Supports Social Strength, While Environmental And Governance Factors Remain Broadly Average Versus Peers.